Responsibilities: Support technical and business directions for solid state battery and cosmetics applications. • Provided inputs to business strategy and proposals in support of Company's directions and engaged with potential clients.

Responsible for market analysis and definition of new product concepts in ophthalmology for strategic growth of Biomedical business. • Prepared comprehensive unmet market/clinical needs landscape in ophthalmology and identified materials based solutions and 2 value based biomedical product concepts. • Created matrix based prioritization map for new product concepts supported by internal and external stakeholder inputs.• Detailed opportunity model and business case analysis for viable product innovation technologies.

Responsibility: R&D management / leadership of ophthalmic biomaterials program.• Led talented team of 9 scientists and engineers in the development of 3 new polymer product solutions and facilitated sustained growth of Company's $40M+CMO business.• Positioned DSM Biomedical as a UV-curable materials solution provider to the medical device industry by building internal capabilities and by leveraging internal and external relationships. • Executed stage-gate PMP and Design Control processes for all R&D projects conforming to ISO quality standards.• Realized operational cost savings through technical solutions and lean manufacturing initiatives. • Increased team visibility through customer and KOL interactions and via external presentations.• Managed resource utilization and championed talent development of high performance teams.

Responsibility: Program leadership of silicone hydrogels and biomaterials for medical devices.• Led cross functional internal and customer R&D/operation teams on new qualifications, continuous improvement and validation activities. Contributed to strategic partnership with Johnson & Johnson Company.• Invented/tested photocurable silicones and polyurethane composite constructs for contact lens and wound healing applications and sampled materials to medical device customers. • Managed R&D evaluation of bioresorbable technology for realized Actamax JV between DSM and DuPont.• Exceeded innovation sales target and YOY growth projections. Inducted in to DSM High Potential group.

Responsible for advancing biomaterials R&D for medical device applications.• Executed rapid translation of key material technologies (photocurable monomers and formulations) to manufactured products. Met commercial launch timelines for 1-DAY ACUVUE® TruEye® silicone hydrogel contact lens (sales of $300M+) by Johnson & Johnson Company. • Qualified and secured multiple vendors for toll manufacturing of internally developed silicone materials, resulting in timely product commercialization by customer.• Demonstrated proof of concept of novel bioresorbable patch materials technology for supporting market need in the wound closure space - Invented novel polymer constructs for mitigating pH drop during implant use.• Managed structure-property assessment of high strength elastomeric bioresorbable polyurethanes for medical devices, leveraging external partnerships. Work highlighted as Biomaterial of the Month in Society for Biomaterials (July 2010).• Managed completion of client projects on bioresorbabale polyurethanes (KCI, Proxy Biomedical, ZSX).

Responsible for conceiving and executing Biomaterials research innovations.• Demonstrated synthesis and development of a innovative single MW photocurable silicone oligomer for contact lens applications - Generated $ 2.7M R&D revenue and garnered commercialization approval for the technology in contact lens product.• Tested and co-invented new routes to high purity UV curable siloxane monomer that is used in existing contact lens product. • Executed safe pilot scale operations for preparation of key raw materials, polymers and hydrogel formulations.• Co-invented biocompatible polyurethane surface technologies (SAME®) – Technology translated in to Company's commercial implantable polymers with improved biocompatibility and processability.• Synthesized surface-modified polyurethanes for blood contacting device application - Co-investigator on NIH grant.• Investigated soft segment structure-property relationships of biostable polyurethanes in close collaboration with medical device client.

Responsible for leading research and development of organic molecular switches for data storage applications. • Demonstrated molecular switching in dithiocarbamate based organic compounds and used creative means to show feasibility. • Managed NSF (Phase I SBIR) funded project on Chiropticenes™ - Chiroptical switches for nanotechnology applications - and trained 2 R&D interns on material synthesis and characterization.• Co-invented chiroptical switching materials and technology for molecular data storage.

• Demonstrated application of organometallic salts as STM calibrants (collaborating externally with NIST) to support nanoscale manufacturing.• Achieved designed synthesis of acrylate, thiol and hydroxyl-functionalized compounds for the preparation of conducting polymers and thin films.

• Accomplished efficient synthesis of new tetrathiafulvalene based electron donor compounds and coordinated with internal team in the electrocrystallization of electrically conducting organometallic charge transfer salts.• Mentored and supervised 2 interns on materials synthesis and characterization.

• Improved adhesion of E-beam radiation-cured solventless acrylic polymeric coatings using creative pretreatment techniques• Chemically modified iron particles with polymerizable groups, via organo silane chemistry, for use in magnetic tape formulations• Contributed as polymer chemistry expert in pilot trials of aqueous magnetic tape formulations, executed at Graham Magnetics, TX